(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Electronics
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > Pharmaceuticals & Biotechnology
 
 
Animal Health - 147
Biotechnology - 46
Drug Delivery - 18
Ethical Pharmaceuticals - 145
Healthcare - 47
Medical Equipment - 58
Pharmaceutical Intermediates - 22
 
 Pharmaceuticals & Biotechnology Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  4  5  6  7  8  9  10  11  12  13  Next »
The World Market for Over The Counter (OTC) Drugs

Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription.  Many pharmaceutical companies seeking more revenue and international exposure have found an opportunity in the development of over-the-counter (OTC) drugs....

 

$3995.00
       
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development

There is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Stem cells also have value as a research tool, as their in vitro study would allow scientists to learn more about the function of various organs and the development of particular diseases; stem cells may also eventually permit drug developers to test emerging therapies on diseased cells....

 

$3995.00
       
World Market for Prescription Dermatological Drugs, (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)

This Kalorama Information report, The Worldwide Market for Prescription Dermatological Drugs represents the eighth time that Kalorama has detailed the various categories of prescription dermatological drugs, describes the global market and identifies major market factors that may help to shape the market for treatments in the future. It is a time of change for this market sector, with OTC product launches, rising skin cancer incidence and acquisitions in the industry, and this report takes those updated details into account in its comprehensive analysis.

Full Coverage of Key Prescription Dermatological Drug Segments

The global market for prescription dermatology drugs includes products in the following categories:

  • Prescription Acne and Rosacea Drugs (Benzoyl, Retinoids, Antibiotics, Other)
  • Prescription Antiaging and Photodamage Drugs (Keratolytics, Moisturizers, Retinoids, Sun-screens, Other Agents)
  • Prescription Dermatitis and Seborrhea Drugs(Topical, Systemic, Others)
  • Prescription Fungal Infection Drugs (Topical, Systemic)
  • Prescription Hair Loss and Hair Removal Drugs(Antiandrogens, Androgen Inhibitors, Others)
  • Prescription Hyperpigmentation/Melasma Drugs(Hyperpigmentation/Melasma Agents, Depigmenting Agents)
  • Prescription Psoriasis Drugs (Topical, Systemic, Other)
  • Prescription Skin Cancer Drugs
  • Other Prescription Skin Disorder Drugs(Antiviral Drugs, Antiparasitic Agents)



 

$3995.00
       
The World Anesthesia Drug Market (General, Local, Adjunctive)

This Kalorama Information report ? The World Anesthesia Drug Market - focuses on three primary segments of anesthesia:
  • General Anesthesia
  • Local Anesthesia
  • Adjunctive Therapies in Anesthesia
The report covers both currently marketed and late stage development anesthesia drugs....

 

$3995.00
       
What's Next In Vaccines in the 2012-2021 Vaccine Pipeline (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets)

Vaccines are one of the most dynamic parts of the pharmaceutical business today but future growth will depend on a considerable amount of potential vaccines in the pipeline.This Kalorama Information report What's Next in Vaccines?...

 

$3995.00
       
The World Market for Cardiovascular Diagnostics

This report, The World Market for Cardiovascular Diagnostics, provides the reader with an overview of the global cardiac diagnostics industry and the trends driving growth. Segments within the cardiac diagnostic market include:

 

$3995.00
       
Trends in Therapeutic Partnering

The Trends in Therapeutic Partnering report provides the most comprehensive and in-depth insight into the 35 most popular therapeutic targets for partnering in the period 2007 to mid 2013.

 

$3995.00
       
PharmaFocus: Market Access Strategies for Antibiotics Targeting Multidrug-Resistant Gram-Negative Bacteria

Since their discovery almost a century ago, antibiotics have revolutionized the global healthcare industry by ushering in an era of significantly reduced morbidity and mortality associated with often-lethal bacterial infections. However, the increasing threat posed by multidrug-resistant (MDR) bacteria, in particular gram-negative organisms, has cast a shadow over these remarkable public health achievements....

 

$3995.00
       
EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2022

Atopic dermatitis or atopic eczema is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children (Bowcock and Cookson, 2004)....

 

$3995.00
       
PharmaFocus: HIV - R&D Strategies towards Cure and Prevention

It has been 30 years since the discovery that HIV is the causative agent of AIDS, and yet no preventative vaccine or cure that allows independence from lifelong antiretroviral treatment exists. Despite some recent setbacks, such as the discontinuation of the HVTN 505 clinical trial due to a trend of increased infection, there have been several promising advances in the cure and prevention of HIV infections.

 

$3995.00
       
EpiCast Report: Endometriosis - Epidemiology Forecast to 2022

Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. Globally, the disease affects up to 10% of women....

 

$3995.00
       
EpiCast Report: Gram-Negative Bacterial Pneumonia - Epidemiology Forecast to 2022

Pneumonia is one of the most common infectious diseases and a major public health concern in both developed and developing countries (Farr et al., 2000)....

 

$3995.00
       
Drug Reconstitution at the Point of Care

Greystone Research Associates is pleased to announce the publication of a new market study. Point-of-Delivery Reconstitution Systems: Therapeutic Markets, Technology, Strategies and Prospects is a comprehensive evaluation and analysis of the technology, devices and participants behind the innovative approaches that address the growing need for packaging and delivering lyophilized drugs for injection....

 

$3850.00
       
APTT: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
Alpha-2 Antiplasmin: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
Antithrombin III: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
D-Dimer: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
Fibrinogen: US, Europe, Japan
Test Volume Forecasts by Country and Market Segment through 2018


The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....

 

$3850.00
       
« Previous     4  5  6  7  8  9  10  11  12  13   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X